Regulating Personalized Medicine

May 1, 2015

The Obama administration's recently announced "Precision Medicine Initiative" will benefit not just from advances in genomics—which allow for an entire human genome to be sequenced in less than a day—but also from significant advances in computing power, the prevalence of electronic health records and even from the 160 million or so smartphones in the hands of U.S. consumers. The plan? To have 1 million volunteers share their genetic data, biological samples and diet and lifestyle information, and to link the data to their electronic health records. That is not as far-fetched a proposition as it might seem.

Reproduced with permission from Life Sciences Law & Industry Report, 9 LSLR 512, 05/01/2015. Copyright 2015 by The Bureau of National Affairs, Inc. (800-372-1033)

The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.


Sharon E. Roberg-Perez, Ph.D.


Co-Chair, Diversity Committee

Ryan M. Schultz


Pronouns: he/him

Related Publications

Summer 2020
The Brave New World of Virtual Notarization
Steven Orloff, Manleen Singh - The Robins Kaplan Spotlight, Vol. 5, No. 2
Summer 2020
What Could be the Harm? Minnesota's Harmless Error Statute
Matthew Frerichs, Ena Kovacevic - The Robins Kaplan Spotlight, Vol. 5, No. 2
Summer 2020
What's a Fiduciary To Do? Considerations for Periods of Uncertainty
Anthony Froio, Denise Rahne - The Robins Kaplan Spotlight, Vol. 5, No. 2
June 17, 2020
Big Data in the Wake of Covid-19—A Conundrum for Enforcers
Meegan Hollywood, Adam Mendel - Bloomberg Law
June 2020
Trade Secrets: Safe as Houses
Christopher Larus, David Prange, Alyssa Bixby-Lawson - Intellectual Property Magazine
Back to Top